Recent Progress in Gonadotropin Therapy

  • Robert L. Collins
Part of the Clinical Perspectives in Obstetrics and Gynecology book series (CPOG)

Abstract

Since the induction of ovulation with human pituitary gonadotropins (hPG) was first achieved in 1958,1 exogenous gonadotropin therapy has been successful in anovulatory infertile women. Ovulation induction using exogenous gonadotropins can be achieved in amenorrheic women with functional ovarian tissue.2–5 Women with chronic anovulation who fail to ovulate with clomiphene citrate, either alone or with human chorionic gonadotropin (hCG), can also be candidates for treatment.6–8

Keywords

Dexamethasone Progesterone Androgen Prolactin Aldosterone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gemzell CA, Diczfalusy E, Tillinger KG. Clinical effect of human pituitary follicle stimulating hormone (FSH). J Clin Endocrinol Metab. 1958; 18: 1333–48.PubMedGoogle Scholar
  2. 2.
    Jones KP, Ravnikar VA, Schiff I. Results of human menopausal gonadotropin therapy at the Boston Hospital for Women (1979–1981). Int J Fertil. 1987; 32: 131–34.PubMedGoogle Scholar
  3. 3.
    Kennedy JL, Adashi EY. Ovulation induction. Obstet Gynecol Clin North Am. 1987; 14: 831–64.PubMedGoogle Scholar
  4. 4.
    March CM, Davajan V, Mishell DR Jr. Ovulation induction in amenorrheic women. Obstet Gynecol. 1979; 53: 8–11.PubMedGoogle Scholar
  5. 5.
    March CM. Therapeutic regimens and monitoring techniques for human menopausal gonadotropin administration. J Reprod Med. 1978; 21: 198–204.PubMedGoogle Scholar
  6. 6.
    Raj SG, Berger MJ, Grimes EM, et al. The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril. 1977; 28: 1280–84.PubMedGoogle Scholar
  7. 7.
    Seibel MM, McArdle C, Smith D, Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril. 1985; 43: 703–08.PubMedGoogle Scholar
  8. 8.
    Venturoli S, Paradisi R, Fabbri R, et al. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary. Obstet Gynecol. 1984; 63: 6–11.PubMedGoogle Scholar
  9. 9.
    Kurachi K, Aono T, Suzuki M. Results of hMG-hCG therapy in 1096 treatment cycles of 2166 Japanese women with anovulatory infertility. Eur J Obstet Gynecol Reprod Biol. 1985; 19: 43–52.Google Scholar
  10. 10.
    Kremmann E, Tavakoli F, Shelden RM, et al. Induction of ovulation with menotropins in women with polycystic ovary syndrome. Am J Obstet Gynecol. 1981; 141: 58–64.Google Scholar
  11. 11.
    Check JH. Treatment of cervical factor with combined high-dose estrogen and human menopausal gonadotropins. Fertil Steril. 1980; 33: 562–63.PubMedGoogle Scholar
  12. 12.
    Check JH, Adelson HG. Improvement of cervical factor by high-dose estrogen and human menopausal gonadotropin therapy with ultrasound monitoring. Obstet Gynecol. 1984; 63: 179–81.PubMedGoogle Scholar
  13. 13.
    Check JH, Wu CH, Dietterich C, et al. The treatment of cervical factor with ethinyl estradiol and human menopausal gonadotropins. Int J Fertil. 1986; 31: 148–52.PubMedGoogle Scholar
  14. 14.
    Lunenfeld B, Insler V. Gonadotropins. In: Diagnosis and treatment of functional infertility. Berlin: Grosse Verlag, 1978: 76–89.Google Scholar
  15. 15.
    Welner S, DeCherney AH, Polan ML. Human menopausal gonadotropins: a justifiable therapy in ovulatory women with long-standing idiopathic infertility. Am J Obstet Gynecol. 1988; 158: 111–17.PubMedGoogle Scholar
  16. 16.
    Halme J, Hammond MG, Bailey L, et al. Lower doses of human menopausal gonadotropin are associated with improved success with in vitro fertilization in women with low body weight. Am J Obstet Gynecol. 1988; 158: 64–65.PubMedGoogle Scholar
  17. 17.
    Ben-Rafael Z, Benadiva CA, Ausmanas M, et al. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril. 1987; 48: 964–68.PubMedGoogle Scholar
  18. 18.
    Bernardus RE, Jones GS, Acosta M, et al. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth. Fertil Steril. 1985; 43: 373–78.PubMedGoogle Scholar
  19. 19.
    Cohen JJ, Debache C, Pigeau F, et al. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles. Fertil Steril. 1984; 42: 360–65.PubMedGoogle Scholar
  20. 20.
    Zondek B, Aschheim S. Des Hormon des hypophysenvorderlappens. Klin Wochenschr. 1928; 6: 831–35.Google Scholar
  21. 21.
    Schwartz J, Jewelewicz R. The use of gonadotropins for induction of ovulation. Fertil Steril. 1981; 35: 3–12.PubMedGoogle Scholar
  22. 22.
    Smith PE, Engle ET. Experimental evidence regarding the role of anterior pituitary in the development and regulation of the genital system. Am J Anat. 1927; 40: 159–217.Google Scholar
  23. 23.
    Cole HH, Hart GH. The potency of blood serum of mares in progressive stages of pregnancy in effecting the sexual maturity of immature rats. Am J Physiol 1930; 93: 57–68.Google Scholar
  24. 24.
    Hamblen EC, Davis CD. Treatment of hypoovarianism by the sequential and cyclic administration of equine and chorionic gonadotropins. Am J Obstet Gynecol. 1945; 50: 137–46.Google Scholar
  25. 25.
    Borth R, Lunenfeld B, de Watteville H. Activite gonadotrope d’un extrait d’urines de femmes en menopause. Experientia. 1954; 10: 264–68.Google Scholar
  26. 26.
    Borth R, Lunenfeld B, Riotton G, et al. Activite gonadotrope d’un extrait des femmes en menopause (2e communication). Experientia. 1957; 13: 115–17.PubMedGoogle Scholar
  27. 27.
    Lunenfeld B, Menzi A, Volet B. Clinical effects of a human postmenopausal gonadotropin. Rass Clin Ter Sci Affini. 1960; 59: 213–16.Google Scholar
  28. 28.
    Donini P, Puzuli D, Montezeniola R. Purification of gonadotropins from human menopause urine. Acta Endocrinol. 1964; 45: 329–34.PubMedGoogle Scholar
  29. 29.
    Borth R, Lunenfeld B, Menzi A. Pharmacologie and clinical effects of a gonadotropin preparation from human postmenopausal urine. In: Albert A, Thomas MC, eds. Human pituitary gonadotropins. Springfield: Charles C. Thomas, 1961: 255.Google Scholar
  30. 30.
    Blankstein J, Mashiach, Lunenfeld B. Induction of ovulation with gonadotropins. In: Ovulation induction and in vitro fertilization. Chicago: Year Book, 1986: 131–54.Google Scholar
  31. 31.
    Rosemberg E, Cortes-Prieto J. First demonstration of induction of ovulation with a hybrid human chorionic gonadotropin compound (AB1ER-CR-2XY). Fertil Steril. 1983; 40: 790–97.PubMedGoogle Scholar
  32. 32.
    Richards JA, Hedin L. Molecular aspects of hormone action in ovarian follicular development, ovulation and luteinization. Annu Rev Physiol. 1988; 50: 441–64.PubMedGoogle Scholar
  33. 33.
    Dlugi AM, Laufer N, DeCherney AH, et al. The day of initiation of human menopausal gonadotropin stimulation affects follicular growth in in vitro fertilization cycles. J In Vitro Fertil Embryo Transfer. 1985; 2: 33–40.Google Scholar
  34. 34.
    Vermesh M, Kletzky OA. Follicle-stimulating hormone is the main determinant of follicular recruitment and development in ovulation induction with human menopausal gonadotropin. Am J Obstet Gynecol. 1987; 157: 1397–1402.PubMedGoogle Scholar
  35. 35.
    Diamond MP, Wentz AC. Ovulation induction with human menopausal gonadotropins. Obstet Gynecol Surv. 1986; 41: 480–90.PubMedGoogle Scholar
  36. 36.
    Filicori M, Santoro N, Merriam GR, et al. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab. 1986; 62: 1136–44.PubMedGoogle Scholar
  37. 37.
    Collins RL, Sopelak V, Williams RF, et al. Prevention of GnRH antagonist-induced lu-teal regression by concurrent exogenous pulsatile gonadotrophin administration in monkeys. Fertil Steril. 1986; 46: 945–53.PubMedGoogle Scholar
  38. 38.
    Groff T, Raj HGM, Talbert LM, et al. Effects of neutralization of luteinizing hormone on corpus luteum function and cyclicity in Ma-caca fascicularis. J Clin Endocrinol Metab. 1984; 59: 1054–57.PubMedGoogle Scholar
  39. 39.
    Coelingh Bennink HJT. Pulsatile administration of LHRH for ovulation induction. In: Shaw RW, Marshall JC, eds. LHRH and its analogues. Their use in gynaecological practice. London: Wright Press, 1989: 92–112.Google Scholar
  40. 40.
    Mais V, Kazer RR, Cetel NS, et al. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe. J Clin Endocrinol Metab. 1986; 62: 1250–55.PubMedGoogle Scholar
  41. 41.
    Weinstein FG, Seibel MM, Taymor ML. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone: the role of supplemental human chorionic gonadotropin in the luteal phase. Fertil Steril. 1984; 41: 546–50.PubMedGoogle Scholar
  42. 42.
    Zeleznik AJ, Hutchison JS. The use of pulsatile GnRH treatment to investigate the regulation of the primate corpus luteum. In: Coelingh Bennink HJT, Dogterom AA, Lappohn RE, et al., eds. Pulsatile GnRH 1985. Naarlem, The Netherlands: Ferring, 1986: 71–79.Google Scholar
  43. 43.
    Berger NG, Zacur HA. Exogenous progesterone for luteal support following gonodatropin-releasing hormone ovulation induction: case report. Fertil Steril. 1985; 44: 133–35.PubMedGoogle Scholar
  44. 44.
    Kenigsberg D, Littman BA, Williams RF, et al. Medical hypophysectomy. II: variability of ovarian response to exogenous gonadotropins. Fertil Steril. 1984; 42: 116–26.PubMedGoogle Scholar
  45. 45.
    Cook AS, Webster BW, Terranova PF, et al. Variation in the biologic and biochemical characteristics of human menopausal gonadotropin. Fertil Steril. 1988; 49: 704–12.PubMedGoogle Scholar
  46. 46.
    Seibel M. Toward understanding the pathophysiology and treatment of polycystic ovarian disease. Semin Reprod Endocrinol. 1984; 2: 297–304.Google Scholar
  47. 47.
    Traub Al, McFaul PB, Sheridan B, et al. Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels. Clin Reprod Fertil. 1987; 5: 167–71.PubMedGoogle Scholar
  48. 48.
    Hoffman DI, Lobo RA, Campeau J, et al. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone. J Clin Endocrinol Metab. 1985; 60: 922–27.PubMedGoogle Scholar
  49. 49.
    Couzinet B, Lestrat N, Brailly S, et al. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab. 1988; 66: 552–56.PubMedGoogle Scholar
  50. 50.
    Reid RL, Fretts R, Van Vugt DA. The theory and practice of ovulation induction with gonadotropin-releasing hormone. Am J Obstet Gynecol. 1988; 158: 173–85.Google Scholar
  51. 51.
    Sueldo CE, Swanson JA. The economics of inducing ovulation with human menopausal gonadotropins versus pulsatile subcutaneous gonadotropin-releasing hormone. Fertil Steril. 1986; 45: 128–29.PubMedGoogle Scholar
  52. 52.
    Dawood MY, Jarrett JC 2d, Choe JK. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Fertil Steril. 1982; 38: 415–18.PubMedGoogle Scholar
  53. 53.
    Farine D, Mashiach S, Ben-Rafael Z, et al. Retrospective evaluation of human menopausal gonadotropin and human chorionic gonadotropin induction of ovulation in galactorrheic and hyperprolactinemic women. Fertil Steril. 1982; 38: 187–89.PubMedGoogle Scholar
  54. 54.
    Tang GW, Tang LC, Ho PC. Transient hyperprolactinaemia in human menopausal gonadotropin induction of ovulation. Int J Fertil. 1984; 29: 136–40.PubMedGoogle Scholar
  55. 55.
    Check JH, Chase JS. Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropin therapy. Fertil Steril. 1984; 42: 919–22.PubMedGoogle Scholar
  56. 56.
    Fleming R, Hamilton MP, Barlow DH, et al. Pregnancy after ovulation induction in a patient with menopausal gonadotropin levels after chemotherapy [letter]. Lancet. 1984; 1399.Google Scholar
  57. 57.
    Jones GS, Aziz A, Urbina G. Clinical use of gonadotropins in conditions of ovarian insufficiency of various etiologies. Fertil Steril. 1961; 12: 217–35.PubMedGoogle Scholar
  58. 58.
    Zimmerman R, Soor B, Braendle W, et al. Gonadotropin therapy of female infertility: analysis of results in 416 cases. Gynecol Obstet Invest. 1982; 14: 1–6.Google Scholar
  59. 59.
    Dodson WC, Whitesides DB, Hughes CL, et al. Superovulation with intrauterine insemination in the treatment of infertility: a possible alternative to gamete intrafallopian transfer and in vitro fertilization. Fertil Steril. 1987; 48: 441–45.PubMedGoogle Scholar
  60. 60.
    Taymor ML, Yussman MA, Gmisnki D. Estrogen monitoring in ovulation induction. Fertil Steril. 1970; 21: 759–62.PubMedGoogle Scholar
  61. 61.
    Webb-Wilson GJ, Arronet GH. Ovulation induction with human menopausal gonadotropins: an evaluation of a variable daily dosage regimen. Int J Fertil. 1977; 22: 225–29.PubMedGoogle Scholar
  62. 62.
    Klopper A, Aiman J, Besser M. Ovarian steroidogenesis resulting from treatment with menopausal gonadotropin. Eur J Obstet Gynecol Reprod Biol. 1974; 4: 25–28.PubMedGoogle Scholar
  63. 63.
    Shaaban MM, Klopper A. Plasma oestradiol and progesterone concentration in the normal menstrual cycle. J Obstet Gynaecol Br Commonw. 1973; 80: 776–80.PubMedGoogle Scholar
  64. 64.
    Tredway DR, Goebelsmann U, Thorneycroft IH, et al. Monitoring induction of ovulation with human menopausal gonadotropin by a rapid estrogen radioimmunoassay. Am J Ob-stet Gynecol 1974; 120: 1035–39.Google Scholar
  65. 65.
    Schenker JG, Weinstein D. Ovarian hyper-stimulation syndrome: a current survey. Fertil Steril. 1978; 30: 255–68.PubMedGoogle Scholar
  66. 66.
    Haning RV, Levin RM, Behrman HR, et al. Plasma estradiol window and urinary estriol glucuronide determinations for monitoring menotropin induction of ovulation. Obstet Gynecol. 1979; 54: 442–47.PubMedGoogle Scholar
  67. 67.
    Duff GB. Ultrasound and ovulation. NZ Med J. 1987; 100: 657–59.Google Scholar
  68. 68.
    Robinson RD, Packer RH, Wilson PC, et al. Assessment of ovulation by ultrasound and plasma estradiol determination. Obstet Gynecol. 1979; 54: 686–91.Google Scholar
  69. 69.
    O’Herlihy C, deCrespigny LJC, Robinson HP. Monitoring ovarian follicular development with real-time ultrasound. Br J Obstet Gynaecol 1980; 87: 613–17.PubMedGoogle Scholar
  70. 70.
    Cabau A, Bessis R. Monitoring of ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin by ultrasound. Fertil Steril. 1981; 36: 178–82.PubMedGoogle Scholar
  71. 71.
    Dornbluth NC, Potter JL, Shepard MK, et al. Assessment of follicular development by ultrasonography and total serum estrogen in human menopausal gonadotropin-stimulated cycles. J Ultrasound Med. 1983; 2: 407–12.PubMedGoogle Scholar
  72. 72.
    Hull ME, Moghissi KS, Magyar DM, et al. Correlation of serum estradiol levels and ultrasound monitoring to assess follicular maturation. Fertil Steril. 1986; 46: 42–45.PubMedGoogle Scholar
  73. 73.
    Marrs RP, Vargyas JM, March CM. Correlation of ultrasonic and endocrinologic measurements in human menopausal gonadotropin therapy. Am J Obstet Gynecol. 1983; 145: 417–21.PubMedGoogle Scholar
  74. 74.
    Seibel MM, McArdle CR, Thompson IE, et al. The role of ultrasound in ovulation induction: a critical appraisal. Fertil Steril. 1981; 36: 573–77.PubMedGoogle Scholar
  75. 75.
    Tulandi T, Hamilton EF, Arronet GH, et al. Ovulation induction by human menopausal gonadotropin with ultrasonic monitoring of the ovarian follicles. Int J Fertil. 1987; 32: 312–15.PubMedGoogle Scholar
  76. 76.
    Hill LM, Coulam CB, Kislak SL, et al. Sonographic evaluation of the cervix during ovulation induction. Am J Obstet Gynecol. 1987; 157: 1170–74.PubMedGoogle Scholar
  77. 77.
    Fleischer AC, Pittaway DE, Beard LA, et al. Sonographic depiction of endometrial changes occurring with ovulation induction. J Ultrasound Med. 1984; 3: 341–46.PubMedGoogle Scholar
  78. 78.
    Insler V, Melmed H, Mashiach S, et al. A Functional classification of patients selected for gonadotropic therapy. Obstet Gynecol. 1968; 32: 620–26.PubMedGoogle Scholar
  79. 79.
    Healy DL, Burger HG. Serum follicle-stimulating hormone, luteinizing hormone, and prolactin during the induction of ovulation with exogenous gonadotropin. J Clin Endocrinol Metab. 1983; 56: 474–78.PubMedGoogle Scholar
  80. 80.
    Olson JL, Rebar RW, Schreiber JR, et al. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril. 1983; 39: 284–91.PubMedGoogle Scholar
  81. 81.
    Collins RL, Williams RF, Hodgen GD. Endocrine consequences of prolonged ovarian hyperstimulation: Hyperprolactinemia, follicular atresia and premature luteinization. Fertil Steril. 1984; 42: 436–45.PubMedGoogle Scholar
  82. 82.
    Hodgen GD. The dominant ovarian follicle. Fertil Steril. 1982; 38: 281–300.PubMedGoogle Scholar
  83. 83.
    Stillman RJ, Williams RF, Lynch A, et al. Selective inhibition of follicle-stimulating hormone by porcine follicular fluid extracts in the monkey: effects on midcycle surges and pulsatile secretion. Fertil Steril. 1983; 40: 823–28.PubMedGoogle Scholar
  84. 84.
    Schenken RS, Hodgen GD. Follicle-stimulating hormone induced ovarian hyperstimulation in monkeys: blockade of the luteinizing hormone surge. J Clin Endocrinol Metab. 1983; 57: 50–55.PubMedGoogle Scholar
  85. 85.
    Laufer N, DeCherney AH, Tarlatzis BC, et al. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes. Fertil Steril. 1984; 42: 198–203.PubMedGoogle Scholar
  86. 86.
    Tulandi T, Mclnnes RA, Arronet GH. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin. Int J Fertil. 1984; 29: 113–17.PubMedGoogle Scholar
  87. 87.
    Schenker JG, Weinstein D. Ovarian hyper-stimulation syndrome: a current survey. Fertil Steril. 1978; 30: 255–68.PubMedGoogle Scholar
  88. 88.
    Navot D, Relou A, Birkenfeld A, et al. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988; 159: 210–15.PubMedGoogle Scholar
  89. 89.
    Kirshon B, Doody MC, Cotton DB, et al. Management of ovarian hyperstimulation syndrome with chlorpheniramine maleate, mannitol, and invasive hemodynamic monitoring. Obstet Gynecol. 1988; 71: 485–87.PubMedGoogle Scholar
  90. 90.
    Blankstein J, Shalev J, Saadon T, et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil Steril. 1987; 47: 597–602.PubMedGoogle Scholar
  91. 91.
    McArdle C, Seibel M, Hann LE, et al. The diagnosis of ovarian hyperstimulation (OHS): the impact of ultrasound. Fertil Steril. 1983; 39: 464–67.PubMedGoogle Scholar
  92. 92.
    Narita O, Shimosuka Y, Suzuki M, et al. Induction of ovulation with human menopausal gonadotropin, with special reference to ovarian hyperstimulation syndrome and hormone excretion. Nagoya J Med Sci. 1980; 43: 7–13.PubMedGoogle Scholar
  93. 93.
    Thaler I, Yoffe N, Kaftory JK, et al. Treatment of ovarian hyperstimulation syndrome: the physiologic basis for a modified approach. Fertil Steril. 1981; 36: 110–13.PubMedGoogle Scholar
  94. 94.
    Ben-Rafael Z, Dor J, Mashiach S, et al. Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/ human chorionic gonadotropin. Fertil Steril. 1983; 39: 157–61.PubMedGoogle Scholar
  95. 95.
    Kemmann E, Bohrer M. Risk factors for spontaneous abortion in menotropintreated women. Fertil Steril. 1987; 48: 571–75.PubMedGoogle Scholar
  96. 96.
    Gemzell C, Roos P. Pregnancies following treatment with human gonadotropins. Am J Obstet Gynecol. 1966; 94: 490–94.PubMedGoogle Scholar
  97. 97.
    Bettendorf G, Braendle W, Sprotte C, et al. Overall results of gonadotropin therapy. In: Insler V, Bettendorf G, eds. Advances and diagnosis in treatment of infertility. New York: Elsevier North-Holland, 1981: 21–34.Google Scholar
  98. 98.
    Tricomi V, Ferrd M, Solish G. The ratio of male and female embryo as determined by the sex chromosome. Am J Obstet Gynecol. 1960; 75: 504–09.Google Scholar
  99. 99.
    Ben-Rafael Z, Matalon A, Blankstein J, et al. Male to female ratio after gonadotropin-induced ovulation. Fertil Steril. 1986; 45: 36–40.PubMedGoogle Scholar
  100. 100.
    Spadoni LR, Cox DW, Smith DC. Use of human menopausal gonadotropin for the induction of ovulation. Am J Obstet Gynecol. 1974; 120: 988–93.PubMedGoogle Scholar
  101. 101.
    Ben-Rafael Z, Mashiach S, Oelsner G, et al. Spontaneous pregnancy and its outcome after human menopausal gonadotropin/human chorionic gonadotropin-induced pregnancy. Fertil Steril. 1981; 36: 560–64.PubMedGoogle Scholar
  102. 102.
    Lam SY, Baker G, Pepperell R, et al. Treatment-independent pregnancies after cessation of gonadotropin ovulation induction in women with oligomenorrhea and anovulatory menses. Fertil Steril. 1988; 50: 26–30.PubMedGoogle Scholar
  103. 103.
    March CM. The use of Pergonal for the induction of ovulation. Clin Obstet Gynecol. 1984; 27: 966–74.PubMedGoogle Scholar
  104. 104.
    Wang CF, Gemzell C. The use of human gonadotropins for induction of ovulation in women with polycystic ovary disease. Fertil Steril. 1980; 33: 479–86.PubMedGoogle Scholar
  105. 105.
    Gemzell C. Induction of ovulation with human gonadotropins. Recent Prog Horm Res. 1965; 21: 179–97.PubMedGoogle Scholar
  106. 106.
    Schoemaker J, Wentz AC, Jones GS, et al. Stimulation of follicular growth with “pure” FSH in patients with anovulation and elevated LH levels. Obstet Gynecol. 1978; 51: 270–77.PubMedGoogle Scholar
  107. 107.
    Collins RL, Gidwani GP, Seiler JC. Improved ovulation in women with PCO receiving exogenous gonadotropins and a GnRH agonist concurrently. 70th Meeting of the Endocrine Society. New Orleans, LA, 1988; 840.Google Scholar
  108. 108.
    Lewinthal D, Taylor PJ, Pattison HA, et al. Induction of ovulation with leuprolide acetate and human menopausal gonadotropin. Fertil Steril. 1988; 49: 585–88.PubMedGoogle Scholar
  109. 109.
    Dodson WC, Hughes CL, Whitesides DB, et al. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab. 1987; 65: 95–100.PubMedGoogle Scholar
  110. 110.
    Charbonnel B, Krempf M, Blanchard P, et al. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins. Fertil Steril. 1987; 47: 920–24.PubMedGoogle Scholar
  111. 111.
    Lanzone A, Fulghesu AM, Spina MA, et al. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly follicle-stimulating hormone in patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1987; 65: 1253–58.PubMedGoogle Scholar
  112. 112.
    March CM, Tredway DR, Michelle DR Jr. Affect of clomiphene citrate upon amount and duration of human menopausal gonadotropin therapy. Am J Obstet Gynecol. 1976; 125: 699–704.PubMedGoogle Scholar
  113. 113.
    Jarrell J, McInnes R, Cooke R, et al. Observations on the combination of clomiphene citrate-human menopausal gonadotropinhuman chorionic gonadotropin in the management of anovulation. Fertil Steril. 1981; 35: 634–37.PubMedGoogle Scholar
  114. 114.
    Evron S, Navot D, Laufer N, et al. Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian disease. Fertil Steril. 1983; 40: 183–86.PubMedGoogle Scholar
  115. 115.
    Diamant YZ, Friedler S. Ovulation induction with pulsatile human menopausal gonadotropins (HMG) administration. Eur J Obstet Gynecol Reprod Biol. 1987; 25: 303–13.PubMedGoogle Scholar
  116. 116.
    Friedler S, Diamant YZ. Ovulation induction with pulsatile human menopausal gonadotropin (HMG) administration. Eur J Obstet Gynecol Reprod Biol. 1987; 25: 303–13.PubMedGoogle Scholar
  117. 117.
    Yuen BH, Pride SM, Sime MO. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy. Am J Obstet Gynecol. 1984; 148: 508–12.Google Scholar
  118. 118.
    Kemmann E, Brandeis VT, Shelden RM, et al. The initial experience with the use of a portable infusion pump in the delivery of human menopausal gonadotropins. Fertil Steril. 1983; 40: 448–53.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1991

Authors and Affiliations

  • Robert L. Collins

There are no affiliations available

Personalised recommendations